NEUKINE VAIL

About

NEUKINE VAIL contains a granulocyte-colony stimulating factor (G-CSF), such as Filgrastim, which is a recombinant human protein that regulates the production and release of neutrophils from the bone marrow. It is primarily used to reduce the incidence and duration of neutropenia, a condition characterized by abnormally low levels of neutrophils (a type of white blood cell), which often occurs following chemotherapy or bone marrow transplantation.

By stimulating the proliferation and differentiation of neutrophil precursors, NEUKINE helps to restore the body's immune defenses, thereby reducing the risk of serious infections in immunocompromised patients. It is administered via subcutaneous injection or intravenous infusion, playing a critical role in supportive care for cancer patients and those undergoing hematopoietic stem cell transplantation.

Uses

• Reduction of neutropenia duration in chemotherapy patients.
• Mobilization of peripheral blood progenitor cells for transplantation.
• Treatment of severe chronic neutropenia.
• Reduction of infection risk in patients undergoing myelosuppressive therapy.

Directions For Use

Administer via subcutaneous injection or intravenous infusion as directed by a healthcare professional. Dosage is individualized based on patient weight and condition.

Benefits

• Increases neutrophil counts.
• Reduces the incidence and duration of neutropenia.
• Decreases the risk of febrile neutropenia and infection.
• Supports recovery after chemotherapy.
• Facilitates stem cell collection for transplantation.
• Improves quality of life for neutropenic patients.

Side Effects

• Bone pain.
• Muscle pain (myalgia).
• Headache.
• Fatigue.
• Nausea.
• Injection site reactions.
• Splenomegaly (enlarged spleen).
• Thrombocytopenia (low platelet count).
• Leukocytosis (high white blood cell count).
• Allergic reactions (rare).
• Acute respiratory distress syndrome (rare).
• Glomerulonephritis (rare kidney inflammation).

Safety Measures

• Alcohol - No specific interaction with alcohol, but general health advice to limit intake during illness or treatment applies.
• Pregnancy - Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Consult your doctor.
• Breastfeeding - It is unknown if G-CSF is excreted in human milk. Exercise caution; consult your doctor before breastfeeding.
• Liver - No specific dose adjustment is typically required for liver impairment.
• Kidney - No specific dose adjustment is typically required for renal impairment.
• Lung - Rare cases of acute respiratory distress syndrome (ARDS) have been reported. Monitor for new or worsening pulmonary symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.